| |
|
|
|
Calithera Biosciences Inc.  
|
|
2.69 -0.02 (-0.01%) |
10-18 16:00 |
|
Open: |
2.69 |
Pre close: |
2.71 |
Target:
|
4.18 
|
|
High: |
2.735 |
Low: |
2.645 |
Resistance:
|
3.57
4.27
|
|
Volume: |
216,512 |
Market Cap: |
145M |
Support:
|
2.45
2.04
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.63
 |
MACD |
MACD(12,26):
|
-0.30 |
|
MA(20): |
2.90 |
Signal(12,26,9): |
-0.32 |
|
MA(100): |
3.99 |
Stochastic Oscillator |
%K(14,3):
|
23.65 |
|
MA(250): |
4.79 |
%D(3): |
17.88 |
|
Average Volume(K) |
3-Month: |
33208
|
52-Week |
High:
|
6.90 |
|
10-Days: |
24365 |
Low: |
2.45 |
|
RSI |
RSI(14):
|
35.16 |
Change(%): |
-48.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.225 |
Return on Equity (ttm) |
-60.2 |
Shares Out. (M) |
53.77 |
|
EPS Est. Current Year |
-0.810 |
Return on Assets (ttm) |
-34.2 |
Shares Float (M) |
46.36 |
|
EPS Est. Next Year |
-1.050 |
PEG Ratio |
-0.02 |
% Held by Insiders |
1.31 |
|
EPS Est. Next Quarter |
-0.230 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
67.90 |
|
Forward EPS |
-1.879 |
Gross Profit (p.s.) |
-0.817 |
Shares Short (K) |
1330 |
|
Book Value (p.s.) |
2.590 |
EBITDA (p.s.) |
-1.647 |
P/E |
-1.21 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.04 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-71.12 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-40.03 |
P/CF |
-2.03 |
|
|
|
|
|
|
